Diazepam pretreatement suppresses morphine withdrawal signs in the mouse

Tsutomu Suzuki, Makoto Tsuda, Minoru Narita, Masahiko Funada, Hirokazu Mizoguchi, Miwa Misawa

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The effect of diazepam on the development of physical dependence on morphine and on the naloxone-precipitated increase in cortical NA turnover were investigated in mice. Co-administration of diazepam (1-4 mg/kg, i.p.) during chronic morphine treatment suppressed the expression of naloxonc (3 mg/kg, s.c.)-precipitated withdrawal signs (jumping, exploratory rearing and weight loss). However, a single injection of diazepam (4 mg/kg, i.p.) in morphine-dependent mice did not affect the expression of naloxone-precipitated withdrawal signs. The 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) level and noradrenaline (NA) turnover (MHPG/NA) in the cerebral cortex were increased by naloxonc (3 mg/kg) challenge. These increases in the cortical MHPG level and NA turnover were significantly prevented by co-administration of diazepam (4 mg/kg, i.p.) during chronic morphine treatment. These findings suggest that the co-administration of diazepam during chronic morphine treatment may prevent some neurochemical changes in the central noradrenergic system during chronic morphine treatment and may suppress the development of physical dependence on morphine. Therefore, the inhibitory action of GABA via benzodiazepine binding sites may play an important role in the development of physical dependence on morphine.

Original languageEnglish
Pages (from-to)349-357
Number of pages9
JournalLife Sciences
Volume58
Issue number4
DOIs
Publication statusPublished - Dec 15 1995
Externally publishedYes

Fingerprint

Diazepam
Morphine
Morphine Dependence
Norepinephrine
Naloxone
Therapeutics
Benzodiazepines
Cerebral Cortex
gamma-Aminobutyric Acid
Weight Loss
Binding Sites
Injections

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Diazepam pretreatement suppresses morphine withdrawal signs in the mouse. / Suzuki, Tsutomu; Tsuda, Makoto; Narita, Minoru; Funada, Masahiko; Mizoguchi, Hirokazu; Misawa, Miwa.

In: Life Sciences, Vol. 58, No. 4, 15.12.1995, p. 349-357.

Research output: Contribution to journalArticle

Suzuki, T, Tsuda, M, Narita, M, Funada, M, Mizoguchi, H & Misawa, M 1995, 'Diazepam pretreatement suppresses morphine withdrawal signs in the mouse', Life Sciences, vol. 58, no. 4, pp. 349-357. https://doi.org/10.1016/0024-3205(95)02294-5
Suzuki, Tsutomu ; Tsuda, Makoto ; Narita, Minoru ; Funada, Masahiko ; Mizoguchi, Hirokazu ; Misawa, Miwa. / Diazepam pretreatement suppresses morphine withdrawal signs in the mouse. In: Life Sciences. 1995 ; Vol. 58, No. 4. pp. 349-357.
@article{30c32c2b4b924dc29accf498a9d9f995,
title = "Diazepam pretreatement suppresses morphine withdrawal signs in the mouse",
abstract = "The effect of diazepam on the development of physical dependence on morphine and on the naloxone-precipitated increase in cortical NA turnover were investigated in mice. Co-administration of diazepam (1-4 mg/kg, i.p.) during chronic morphine treatment suppressed the expression of naloxonc (3 mg/kg, s.c.)-precipitated withdrawal signs (jumping, exploratory rearing and weight loss). However, a single injection of diazepam (4 mg/kg, i.p.) in morphine-dependent mice did not affect the expression of naloxone-precipitated withdrawal signs. The 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) level and noradrenaline (NA) turnover (MHPG/NA) in the cerebral cortex were increased by naloxonc (3 mg/kg) challenge. These increases in the cortical MHPG level and NA turnover were significantly prevented by co-administration of diazepam (4 mg/kg, i.p.) during chronic morphine treatment. These findings suggest that the co-administration of diazepam during chronic morphine treatment may prevent some neurochemical changes in the central noradrenergic system during chronic morphine treatment and may suppress the development of physical dependence on morphine. Therefore, the inhibitory action of GABA via benzodiazepine binding sites may play an important role in the development of physical dependence on morphine.",
author = "Tsutomu Suzuki and Makoto Tsuda and Minoru Narita and Masahiko Funada and Hirokazu Mizoguchi and Miwa Misawa",
year = "1995",
month = "12",
day = "15",
doi = "10.1016/0024-3205(95)02294-5",
language = "English",
volume = "58",
pages = "349--357",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Diazepam pretreatement suppresses morphine withdrawal signs in the mouse

AU - Suzuki, Tsutomu

AU - Tsuda, Makoto

AU - Narita, Minoru

AU - Funada, Masahiko

AU - Mizoguchi, Hirokazu

AU - Misawa, Miwa

PY - 1995/12/15

Y1 - 1995/12/15

N2 - The effect of diazepam on the development of physical dependence on morphine and on the naloxone-precipitated increase in cortical NA turnover were investigated in mice. Co-administration of diazepam (1-4 mg/kg, i.p.) during chronic morphine treatment suppressed the expression of naloxonc (3 mg/kg, s.c.)-precipitated withdrawal signs (jumping, exploratory rearing and weight loss). However, a single injection of diazepam (4 mg/kg, i.p.) in morphine-dependent mice did not affect the expression of naloxone-precipitated withdrawal signs. The 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) level and noradrenaline (NA) turnover (MHPG/NA) in the cerebral cortex were increased by naloxonc (3 mg/kg) challenge. These increases in the cortical MHPG level and NA turnover were significantly prevented by co-administration of diazepam (4 mg/kg, i.p.) during chronic morphine treatment. These findings suggest that the co-administration of diazepam during chronic morphine treatment may prevent some neurochemical changes in the central noradrenergic system during chronic morphine treatment and may suppress the development of physical dependence on morphine. Therefore, the inhibitory action of GABA via benzodiazepine binding sites may play an important role in the development of physical dependence on morphine.

AB - The effect of diazepam on the development of physical dependence on morphine and on the naloxone-precipitated increase in cortical NA turnover were investigated in mice. Co-administration of diazepam (1-4 mg/kg, i.p.) during chronic morphine treatment suppressed the expression of naloxonc (3 mg/kg, s.c.)-precipitated withdrawal signs (jumping, exploratory rearing and weight loss). However, a single injection of diazepam (4 mg/kg, i.p.) in morphine-dependent mice did not affect the expression of naloxone-precipitated withdrawal signs. The 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) level and noradrenaline (NA) turnover (MHPG/NA) in the cerebral cortex were increased by naloxonc (3 mg/kg) challenge. These increases in the cortical MHPG level and NA turnover were significantly prevented by co-administration of diazepam (4 mg/kg, i.p.) during chronic morphine treatment. These findings suggest that the co-administration of diazepam during chronic morphine treatment may prevent some neurochemical changes in the central noradrenergic system during chronic morphine treatment and may suppress the development of physical dependence on morphine. Therefore, the inhibitory action of GABA via benzodiazepine binding sites may play an important role in the development of physical dependence on morphine.

UR - http://www.scopus.com/inward/record.url?scp=13344277990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13344277990&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(95)02294-5

DO - 10.1016/0024-3205(95)02294-5

M3 - Article

C2 - 8538371

AN - SCOPUS:13344277990

VL - 58

SP - 349

EP - 357

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 4

ER -